Atlas Trials

Stage IV Non-Small Cell Lung Cancer AJCC v7

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Non-Small Cell Lung Cancer AJCC v7

RecordFirmDate
Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer (NCT03520842)Stanford University2018-08-14
Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer (NCT03455556)Mayo Clinic2018-08-10
CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer (NCT03370159)Wake Forest University Health Sciences2018-06-01
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer (NCT03492801)University of Southern California2017-12-11
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma (NCT03229278)Rutgers, The State University of New Jersey2017-10-03
Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer (NCT02846792)University of Washington2017-06-14
Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC (NCT03066206)M.D. Anderson Cancer Center2017-03-17
Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer (NCT02503358)OHSU Knight Cancer Institute2016-07-21
Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016)Fred Hutchinson Cancer Center2015-05-22
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer (NCT01727076)National Cancer Institute (NCI)2013-02-15
Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer (NCT01725165)M.D. Anderson Cancer Center2012-11-28
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT01642251)National Cancer Institute (NCI)2012-09-28
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy (NCT00693992)National Cancer Institute (NCI)2008-06-15
Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer (NCT00698815)National Cancer Institute (NCI)2008-04-15
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer (NCT00096265)National Cancer Institute (NCI)2004-10-06

Track Stage IV Non-Small Cell Lung Cancer AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.